Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis

Completed · Phase 2 · Has a placebo group

Conditions studied: Allergic Conjunctivitis

In brief

The purpose of this study is to determine the efficacy and safety of the administration of cyclosporine and prednisolone acetate compared to placebo in the treatment of allergic conjunctivitis.

Key facts

Study ID

NCT01120132

Run by

Fovea Pharmaceuticals SA

People needed

716

Starts

2010-05-01

Expected to finish

2010-08-01

Last updated by the study team

2012-03-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• history of ocular allergies and a positive skin test reaction to perennial allergens within the past 24 months and a history of chronic eye irritation
• visual acuity score ≥ 0.60 (EDTS)
• negative urine pregnancy test for female patients, and use of adequate birth control throughout the study period.

You may not qualify if…

• active ocular infection; preauricular lymphadenopathy or ocular condition that could affect study; glaucoma or abnormal intraocular pressure; ocular surgery within past 3 months; history of asthma, pregnancy or nursing
• contraindications or known allergies to the study drug(s)

Where it is running

• ORA — Andover, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.